Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.9000 (0.82%) ($4.9000 - $4.9000) on Thu. May. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.31% (three month average) | RSI | 26 | Latest Price | $4.9000(0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.8% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(41%) IBB(39%) ARKK(37%) ARKG(36%) XAR(34%) | Factors Impacting ATRA price | ATRA will decline at least -2.655% in a week (0% probabilities). VIXM(-36%) VXX(-25%) UNG(-23%) USO(-18%) XOP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.655% (StdDev 5.31%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-22.43(-557.76%) | Resistance Level | $5.66 | 5 Day Moving Average | $4.91(-0.2%) | 10 Day Moving Average | $5.1(-3.92%) | 20 Day Moving Average | $5.66(-13.43%) | To recent high | -61.9% | To recent low | 4.5% | Market Cap | $364m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |